The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119237872 11923787 2 F 20160912 20160118 20160915 EXP US-ROCHE-1439211 ROCHE , UPPAL N, WAGNER S, BENDELL J, THADDEUS B, WADE, S, NEMUNAITIS J, STELLA P, PIPAS J, WAINBERG Z, MANGES R, GARRETT W, HUNTER D, CLARK J, LEOPOLD L, LEVY R AND SANDOR V. RESULTS FROM A PHASE 2 STUDY OF RUXOLITINIB OR PLACEBO WITH CAPECITABINE AS SECOND-LINE THERAPY IN PATIENTS WITH METASTATIC PANCREATIC CANCER: THE RECAP TRIAL. ANNALS OF ONCOLOGY 2014 JUN;25(SUPP 2):II115-II116. 0.00 Y 0.00000 20160915 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119237872 11923787 1 PS CAPECITABINE. CAPECITABINE 1 Oral FROM DAYS 1-14 OF A 21-DAY CYCLE. U 20896 1000 MG/M**2 BID
119237872 11923787 2 SS RUXOLITINIB RUXOLITINIB 1 Oral ON DAYS 1-21 OF A 21-DAY CYCLE U 0 15 MG TABLET BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119237872 11923787 1 Pancreatic carcinoma metastatic
119237872 11923787 2 Pancreatic carcinoma metastatic

Outcome of event

Event ID CASEID OUTC COD
119237872 11923787 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
119237872 11923787 Abdominal pain
119237872 11923787 Abdominal pain upper
119237872 11923787 Anaemia
119237872 11923787 Ascites
119237872 11923787 Asthenia
119237872 11923787 Back pain
119237872 11923787 Constipation
119237872 11923787 Decreased appetite
119237872 11923787 Deep vein thrombosis
119237872 11923787 Dehydration
119237872 11923787 Diarrhoea
119237872 11923787 Dizziness
119237872 11923787 Embolism
119237872 11923787 Fatigue
119237872 11923787 Hyponatraemia
119237872 11923787 Hypotension
119237872 11923787 Nausea
119237872 11923787 Neutropenia
119237872 11923787 Oedema peripheral
119237872 11923787 Palmar-plantar erythrodysaesthesia syndrome
119237872 11923787 Peripheral sensory neuropathy
119237872 11923787 Pneumonia
119237872 11923787 Pneumonia aspiration
119237872 11923787 Pneumonia klebsiella
119237872 11923787 Portal vein thrombosis
119237872 11923787 Pulmonary embolism
119237872 11923787 Pyrexia
119237872 11923787 Stomatitis
119237872 11923787 Thrombocytopenia
119237872 11923787 Thrombosis
119237872 11923787 Trousseau's syndrome
119237872 11923787 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found